Stock Events

Stock Events

Chromocell Therapeutics (CHRO) Q2 2024 Earnings

15MayConfirmed

Q1 1

Q2 2024

-2.9

-2.12

-1.33

-0.55

Details

Expected EPS

N/A

Actual EPS

-0.55

Surprise EPS

-0.55

Surprise Percent

+∞%

Description

Chromocell Therapeutics (CHRO) has reported earnings of -0.55 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.